Association of aldose reductase gene (AKR1B1) polymorphism with diabetic retinopathy

被引:28
|
作者
Kaur, Navdeep [1 ]
Vanita, Vanita [1 ]
机构
[1] Guru Nanak Dev Univ, Dept Human Genet, Amritsar 143005, Punjab, India
关键词
AKR1B1; Case-control association study; Diabetic retinopathy; DNA sequencing; Type; 2; diabetes; -106C > T polymorphism; MICROVASCULAR COMPLICATIONS; JAPANESE PATIENTS; C(-106)T POLYMORPHISM; OXIDATIVE STRESS; CHINESE PATIENTS; PROMOTER REGION; POLYOL PATHWAY; MELLITUS; SUSCEPTIBILITY; NEPHROPATHY;
D O I
10.1016/j.diabres.2016.08.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Present study aimed to investigate the association of aldose reductase (AKR1B1) gene polymorphism (-106C > T; rs759853) with diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) patients from north India. Methods: The present case-control association study recruited 926 subjects, including 487 DR patients and 439 individuals with confirmed T2DM as controls (CDR). AKR1B1 -106C > T polymorphism analysis in these 926 subjects was performed by polymerase chain reaction and direct DNA sequence analysis. Statistical analysis was performed using SPSS package. Results: Statistically significant differences were observed between the two analyzed groups in the age of onset of diabetes (p = 0.000) and duration of diabetes (p = 0.000). Genotype distribution of AKR1B1 -106C > T polymorphism differed significantly between DR and CDR groups (p = 0.02), however, distribution of allele frequency did not differ significantly (p = 0.19). Binary logistic regression analyses showed an association of homozygous recessive TT genotype with diabetic retinopathy (OR: 1.61%, 95% CI, 1.39-2.284, p < 0.01) in comparison to wild type CC genotype. Conclusions: These findings suggest a statistically significant association of AKR1B1 -106C > T polymorphism with retinopathy in North Indian patients. To our knowledge, this is the first report of association of -106C > T polymorphism in AKR1B1 in DR patients from India. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [41] Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition
    Liu, Mingyue
    Qin, Xiaochun
    Li, Jing
    Jiang, Yuting
    Jiang, Junjie
    Guo, Jiwei
    Xu, Hao
    Wang, Yousen
    Bi, Hengtai
    Wang, Zhiliang
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2024, 26 (12) : 9295 - 9308
  • [42] Aldose reductase polymorphism is not associated with retinopathy in Type II diabetic patients.
    Groves, CJ
    Izmajlowicz, ML
    Horton, VA
    Wat, NMS
    Owen, RJ
    Stratton, IR
    Green, FR
    Turner, RC
    DIABETOLOGIA, 1999, 42 : A120 - A120
  • [43] Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10
    Cousido-Siah, Alexandra
    Ruiz, Francesc X.
    Crespo, Isidro
    Porte, Sergio
    Mitschler, Andre
    Pares, Xavier
    Podjarny, Alberto
    Farres, Jaume
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 234 : 290 - 296
  • [44] Induced fit binding of aldose reductase inhibitors to AKR1B10
    Shah, Anup
    Shinde, Ranajit
    Kare, Pavan
    Hymavathi, V.
    Chavan, Swapnil
    Sobhia, M. Elizabeth
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (07) : 1245 - 1252
  • [45] Induced fit binding of aldose reductase inhibitors to AKR1B10
    Anup Shah
    Ranajit Shinde
    Pavan Kare
    V. Hymavathi
    Swapnil Chavan
    M. Elizabeth Sobhia
    Medicinal Chemistry Research, 2012, 21 : 1245 - 1252
  • [46] Regulation of AKR1B1 by thyroid hormone and its receptors
    Liao, Chen-Shin
    Tai, Pei-Ju
    Huang, Ya-Hui
    Chen, Ruey-Nan
    Wu, Sheng-Ming
    Kuo, Lu-Wei
    Yeh, Chau-Ting
    Tsai, Ming-Ming
    Chen, Wei-Jan
    Lin, Kwang-Huei
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 307 (1-2) : 109 - 117
  • [47] Expression of the aldo-ketoreductases AKR1B1 and AKR1B10 in human cancers
    Laffin, Brian
    Petrash, J. Mark
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [48] Aldose Reductase/Polyol Inhibitors for Diabetic Retinopathy
    Obrosova, Irina G.
    Kador, Peter F.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (03) : 373 - 385
  • [49] ALDOSE REDUCTASE INHIBITION AND DIABETIC-RETINOPATHY
    HOTTA, N
    KAKUTA, H
    ANDO, F
    MIYAKE, Y
    AWAYA, S
    FUKASAWA, H
    KOH, N
    SAKAMOTO, N
    DIABETES 1988, 1989, 800 : 229 - 232
  • [50] Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus
    Demaine, A
    Cross, D
    Millward, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (13) : 4064 - 4068